Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
524 studies found for:    Open Studies | "Uterine Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Condition: Metastatic Endometrial Cancer
Intervention: Drug: Avelumab
22 Not yet recruiting LLETZ Under Direct Colposcopic Vision
Condition: Uterine Cervical Dysplasia
Interventions: Device: LLETZ with colposcopy;   Other: LLETZ without colposcopy
23 Not yet recruiting Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment
Condition: Uterine Cervical Neoplasms
24 Recruiting PET (Positron Emission Tomography) Imaging Studies With NIS Reporter
Conditions: Myeloma;   Endometrial Cancer
Intervention: Drug: BF4
25 Recruiting Irisin Hormone Levels in Endometrial Hyperplasia
Condition: Endometrial Hyperplasia
26 Not yet recruiting Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
Conditions: Bleeding;   Implants;   Breakthrough Bleeding
Interventions: Drug: Tamoxifen;   Drug: Placebo;   Drug: Tamoxifen (open label)
27 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
28 Recruiting Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Condition: Recurrent Endometrial Cancer
Intervention: Drug: Pembrolizumab
29 Recruiting The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection
Condition: Uterine Cancer
Interventions: Drug: Dexmedetomidine group;   Drug: Control group
30 Recruiting Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers
Condition: Advanced Cervical Cancer
Intervention: Procedure: 'OSNA stadification during surgery'
31 Not yet recruiting Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
Condition: Cervical Cancer
Interventions: Biological: Tetravalent recombinant human papilloma virus vaccine (6,11,16,18 type) (Hansenula polymorpha);   Biological: placebo
32 Not yet recruiting A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension
Conditions: Pelvic Organ Prolapse;   Cystocele;   Uterine Prolapse
Intervention: Device: Absorbent suture (polydioxanone) and Permanent suture (Gore-Tex CV2)
33 Recruiting Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Stage IB Cervical Cancer;   Stage II Cervical Cancer;   Stage III Cervical Cancer
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: PDR Brachytherapy;   Drug: Cisplatin
34 Recruiting Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer
Condition: Squamous Cell Carcinoma of Cervix
Intervention: Radiation: Simultaneous boost along with chemo
35 Recruiting Outcomes of Uterine Rupture
Condition: Maternal Mortality
Intervention: Procedure: repair of rupture
36 Not yet recruiting Characterization of Immunosuppressive Signing of Cervical Cancer
Condition: Cervical Cancer
Intervention: Biological: Blood sample
37 Recruiting Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Conditions: Breast Carcinoma;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Uterine Corpus Cancer;   Uterine Corpus Carcinosarcoma
Interventions: Drug: Metformin Hydrochloride;   Drug: Doxycycline
38 Recruiting Institut Paoli Calmettes Cervical Cancer Database
Condition: Uterine Cervical Neoplasms
Intervention: Other: Data collection
39 Not yet recruiting Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Drug: BVAC-C
40 Recruiting Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer
Condition: Cervical Cancer
Intervention: Other: brachytherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years